Circulating microRNA profile predicts disease progression in patients receiving second-line treatment of lapatinib and capecitabine for metastatic pancreatic cancer
暂无分享,去创建一个
J. Marshall | A. Wellstein | L. Weiner | M. Pishvaian | N. Shivapurkar | Xuefei Tian | A. He | X. Zhi | Dan Zhou | Zheng Wu | L. Ley | J. Hwang